Cargando…

Clinical Value of PET.CT Based on Big Data in Colorectal and Peritoneal Metastatic Cancer

This study focuses on the evaluation of the clinical utility of PET-CT imaging in peritoneal metastases and colorectal cancer. One hundred patients with colorectal peritoneal metastases, who underwent whole-body PET-CT imaging from January 2015 to December 2019, were selected as the experimental gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Lili, Yang, Chuanhua, Liu, Wenneng, Li, Dong, Jiang, Zongze, Zhou, Huijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546711/ https://www.ncbi.nlm.nih.gov/pubmed/36262991 http://dx.doi.org/10.1155/2022/6120337

Ejemplares similares

A retrospective study based on SEER database: not all high-risk factors are equal for stage II colon cancer
por: Li, Dong, et al.
Publicado: (2022)

18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumor
por: Queiroz, Marcello Moro, et al.
Publicado: (2021)

Prevalence and Characteristics of Incidentalomas Discovered by Whole Body FDG PETCT
por: Pampaloni, Miguel Hernandez, et al.
Publicado: (2012)

Application value of 18F-FDG PETCT imaging in the clinical initial diagnosis and follow-up of primary lesions of cervical cancer
por: Tan, Beibei, et al.
Publicado: (2020)

Albumin exfoliated titanium disulfide nanosheet: a multifunctional nanoplatform for synergistic photothermal/radiation colon cancer therapy
por: Cao, Chen, et al.
Publicado: (2019)

CircPRMT5 circular RNA promotes proliferation of colorectal cancer through sponging miR‐377 to induce E2F3 expression
por: Yang, Bairen, et al.
Publicado: (2020)

Zosteriform cutaneous metastases from an occult primary malignancy of lung identified by whole-body FDG PETCT imaging
por: Subramanyam, Padma, et al.
Publicado: (2016)

Value of (18)F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary
por: Li, Yuekai, et al.
Publicado: (2020)

CT, MRI and PET imaging in peritoneal malignancy
por: Patel, Chirag M., et al.
Publicado: (2011)

PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum
por: Wang, Shao-Bo, et al.
Publicado: (2017)

LINC01303 functions as a competing endogenous RNA to regulate EZH2 expression by sponging miR‐101‐3p in gastric cancer
por: Cao, Chen, et al.
Publicado: (2019)

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
por: Skougaard, Kristin, et al.
Publicado: (2014)

Peritoneal Mouse as Detected on (18)F-FDG PET-CT
por: Allam, Talha, et al.
Publicado: (2013)

The prognostic value of PET and PET/CT in cervical cancer
por: Grigsby, Perry W.
Publicado: (2008)

The prognostic value of PET and PET/CT in cervical cancer
por: Koh, Dow-Mu, et al.
Publicado: (2008)

The value of (18)F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer
por: Hong, Jun-jie, et al.
Publicado: (2020)

Peritoneal lymphomatosis: CT and PET/CT findings and how to differentiate between carcinomatosis and sarcomatosis
por: Cabral, Fernanda C., et al.
Publicado: (2013)

The Role of (18)F-FDG PET/CT in the Evaluation of Peritoneal Thickening of Undetermined Origin
por: Chen, Ruohua, et al.
Publicado: (2016)

Statistical Modeling of Relations Between PET/CT Parameters and CEA in Recurrent and Metastatic Colorectal Cancer
por: Milardovic, Renata, et al.
Publicado: (2023)

The Prognostic Value of (18)F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
por: Arslan, Esra, et al.
Publicado: (2020)

The relationship between (18)F-FDG-PETCT-derived tumour metabolic activity, nutritional risk, body composition, systemic inflammation and survival in patients with lung cancer
por: Dolan, Ross D., et al.
Publicado: (2020)

Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on (18)F-FDG PET/CT for Patients with Colorectal Cancer
por: Liu, Xin, et al.
Publicado: (2022)

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
por: Woff, Erwin, et al.
Publicado: (2016)

Obtaining value from big data for service systems: big data technology
por: Kaisler, Stephen H, et al.
Publicado: (2019)

The big book of pets
por: Green, Margaret, ed
Publicado: (1966)

Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer
por: Buvat, Irène, et al.
Publicado: (2012)

Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma
por: Kulanthaivelu, Roshini, et al.
Publicado: (2022)

Big data for managers: creating value
por: Malviya, Atal, et al.
Publicado: (2019)

Molecular characterization of colorectal cancer related peritoneal metastatic disease
por: Lenos, Kristiaan J., et al.
Publicado: (2022)

Comparison of (68)Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer
por: Regula, Naresh, et al.
Publicado: (2022)

FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate
por: Liu, Yiyan
Publicado: (2008)

FDG-PET/CT findings of a metastatic pituitary tumor
por: Ilkhchoui, Yashar, et al.
Publicado: (2010)

Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT
por: Zhou, Nina, et al.
Publicado: (2021)

The Use of PET-CT in the Assessment of Patients with Colorectal Carcinoma
por: O'Connor, Owen J., et al.
Publicado: (2011)

Pitfalls and value of organ specific approach in evaluating indeterminate lesions detected on CT in colorectal cancer by [F18] FDG PET/CT
por: Marashdeh, Wael M., et al.
Publicado: (2020)

Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosis
por: Kis, Adrian, et al.
Publicado: (2013)

The Values and Limitations of FDG-PET/CT for Diagnosis of Hibernoma
por: Park, Jong Hoon, et al.
Publicado: (2015)

(18)F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12)
por: Nakamura, Masato, et al.
Publicado: (2021)

Tailoring the clinical management of colorectal cancer by (18)F-FDG PET/CT
por: Shi, Yang, et al.
Publicado: (2022)

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
por: De Bruyne, S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hcser2ubm7c5no3qslgmkjibv4